Gα12 Drives Invasion of Oral Squamous Cell Carcinoma through Up-Regulation of Proinflammatory Cytokines
Open Access
- 7 June 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (6) , e66133
Abstract
Oral squamous cell carcinoma (OSCC) ranks among the top ten most prevalent cancers worldwide. Like most head and neck squamous cell carcinomas (HNSCCs), OSCC is highly inflammatory and aggressive. However, the signaling pathways triggering the activation of its inflammatory processes remain elusive. G protein-coupled receptor signaling regulates the inflammatory response and invasiveness of cancers, but it remains unclear whether Gα12 is a critical player in the inflammatory cytokine pathway during the tumorigenesis of OSCC. This study was undertaken to determine the role of Gα12 signaling in the regulation of proinflammatory cytokines in their mediation of OSCC invasion. We found that both the transcription and protein levels of Gα12 are up-regulated in OSCC tumors. The elevated Gα12 expressions in OSCC patients also correlated with extra-capsular spread, an indicator of tumor invasiveness in HNSCCs. This clinical finding was supported by the studies of overexpression and RNAi knockdown of Gα12 in OSCC cells, which demonstrated that Gα12 promoted tumor cell migration and invasion. To understand how Gα12 modulates OSCC invasiveness, we analyzed key biological processes in microarray data upon depletion of Gα12 and found that cytokine- and other immune-related pathways were severely impaired. Importantly, the mRNA levels of IL-6 and IL-8 proinflammatory cytokines in clinical samples were found to be significantly correlated with the increased Gα12 levels, suggesting a potential role of Gα12 in modulating the IL-6 and IL-8 expressions. Supporting this hypothesis, overexpression or RNAi knockdown of Gα12 in OSCC cell lines both showed that Gα12 positively regulated the mRNA and protein levels of IL-6 and IL-8. Finally, we demonstrated that the Gα12 promotion of tumor cell invasiveness was suppressed by the neutralization of IL-6 and IL-8 in OSCC cells. Together, these findings suggest that Gα12 drives OSCC invasion through the up-regulation of IL-6 and IL-8 cytokines.Keywords
This publication has 50 references indexed in Scilit:
- Proteomics-based identification of plasma biomarkers in oral squamous cell carcinomaJournal of Pharmaceutical and Biomedical Analysis, 2013
- Interleukin-6 as a therapy target in oral squamous carcinomaExpert Opinion on Therapeutic Targets, 2012
- Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorptionOral Oncology, 2012
- Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cellsCancer Letters, 2010
- Current and potential inflammation targeted therapies in head and neck cancerCurrent Opinion in Pharmacology, 2009
- Immunohistochemical expression of interleukin‐4, ‐6, ‐8, and ‐12 in inflammatory cells in surrounding invasive front of oral squamous cell carcinomaHead & Neck, 2009
- Neoadjuvant concurrent radiochemotherapy followed by surgery in advanced oral squamous cell carcinoma (OSCC): A retrospective analysis of 207 patientsOral Oncology, 2008
- The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasisProceedings of the National Academy of Sciences, 2006
- Overexpression of G protein-coupled receptors in cancer cells: Involvement in tumor progressionInternational Journal of Oncology, 2005
- Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.2005